Oliver Peters - Concepedia

Author

Oliver Peters

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Alison M. Goate, Annika Spottke, Bosco, Paola, C.K. Wu, Christoph Laske, Chuang-Kuo Wu, Daniel Janowitz, Fahri Küçükali, Felix Menne, Florence Pasquier

526

Publications

22.3K

Citations

H-Index

151

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin German Center for Neurodegenerative Diseases University of Bonn University of Göttingen University of Cologne

About

Oliver Peters is an author at Charité - Universitätsmedizin Berlin specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	44	5.3K
2	Health Sciences	8	8	761
3	Engineering	2	2	49
4	Natural Sciences	2	2	679
5	Education	1	1	29

Oliver Peters

160

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, Nature Genetics	2022	2.3K
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration Sabrina Lehmann, Christina Krüger, Boyoun Park, Nature Neuroscience InflammationToll-like ReceptorsMedicineImmunologyRna Biology	2012	758
Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood Sebastian Memczak, Panagiotis Papavasileiou, Oliver Peters, PLoS ONE Rna IsoformsImmunologyMolecular BiologyPathologyNucleic Acid Biomarkers	2015	628
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease Lesley Jones, Peter Holmans, Marian L. Hamshere, PLoS ONE	2010	605
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study Henryk Barthel, Hermann‐Josef Gertz, S. Dresel, The Lancet Neurology Neurodegenerative DiseasesDiagnostic StudyAlzheimer's DiseaseCerebral Amyloid-β PetNeurochemical Biomarkers	2011	574
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline Johannes vom Berg, Stefan Prokop, Kelly R. Miller, Nature Medicine InflammationNeurodegenerative DiseasesCognitive DeclineAlzheimer's DiseaseMedicine	2012	403
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage Stephanie J. B. Vos, Frans R.J. Verhey, Lutz Frölich, Brain	2015	384
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores Itziar de Rojas, Sonia Moreno–Grau, Niccoló Tesi, Nature Communications	2021	320
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease Jakob M. Bader, Philipp E. Geyer, Johannes Müller, Molecular Systems Biology	2020	297
Increased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat Oliver Peters, Tobias Back, Ute Lindauer, Journal of Cerebral Blood Flow & Metabolism	1998	294

Page 1